• Apexian Pharmaceuticals, an Indiana -
based clinical stage biotechnology company, raised Series A funding of an undisclosed amount.
• Eureka Therapeutics Inc, an Emeryville, Calif. -
based clinical stage biotechnology focused on treating solid tumors, raised $ 60 million in Series D funding.
Not exact matches
• Myonexus Therapeutics, a New Albany, Oh. -
based clinical -
stage biotechnology company developing transformative gene therapies for limb - girdle muscular dystrophies, raised $ 2.5 million in seed funding.
Alachua, Fla. -
based AGTC is a
clinical -
stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe inherited orphan diseases in ophthalmology.